SCSheng Cao

Sheng Cao

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Sheng Cao has a total of 69 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Left ventricular hypertrophy and myocardial work in amateur marathon runners

    by Juncheng Wang, Haiyan Tian, Qinghong Zeng, Sheng Cao, Yanggan Wang

    Aims: To investigate the left ventricular hypertrophy (LVH) and myocardial work, and their association in amateur marathon runners. Methods: Amateur marathon runners were categorized into LVH and non-LVH groups according to international guidelines and further classified by gender. Healthy individuals without established exercise habits served as the control group. The global work index (GWI), global constructive work (GCW), global work efficiency (GWE), and global wasted work (GWW) were calculated using the pressure-strain loop methodology. The Firth logistic regression model was used to analyze the factors influencing LVH. Spearman correlation analysis was utilized to examine the relationship between running characteristics and myocardial work parameters. Results: Compared with the control group, both the non-LVH and LVH groups exhibited significant enlargement of the left atrium and left ventricle (LV), increased wall thickness, and elevated LV mass, with the LVH group showing more pronounced changes. The non-LVH group demonstrated the highest GWI and GCW, while the LVH group exhibited the lowest GWE and GWW. Regression analysis indicated that the weekly running distance is associated with LVH (OR = 1.97, CI: 1.37–3.48) in male runners. In the overall runner cohort, the weekly running distance was negatively correlated with GWE ( r = −0.37, P = 0.002) and positively correlated with GWW ( r = 0.34, P = 0.004). Conclusion: Excessive remodeling leading to LVH may be associated with decreased myocardial work efficiency in amateur marathon runners. The weekly running distance may be a factor influencing LVH and myocardial work.

  • Open Access

    A fully convolutional neural network for the quantification of mitral regurgitation in echocardiography

    by Lu Zhong, Qing Deng, Yin Wang, Hongning Song, Jinling Chen, Qing Zhou, Jinsheng Xiao, Sheng Cao

    Original Article A fully convolutional neural network for the quantification of mitral regurgitation in echocardiography Lu Zhong, Qing Deng, Yin Wang, Hongning Song, Jinling Chen, Qing Zhou, Jinsheng Xiao, Sheng Cao


  • Open Access

    Identification of the Vulnerability of Atherosclerotic Plaques by a Photoacoustic/Ultrasonic Dual-Modal cRGD Nanomolecular Probe

    by Caigui Yu, Lu Zhong, Yanxiang Zhou, Nan Jiang, Jinling Chen, Sheng Cao

    Objective: To explore the feasibility of using cRGD-GNR-PFP-NPs to assess plaque vulnerability in an atherosclerotic plaque mouse model by dual-modal photoacoustic/ultrasonic imaging. Methods: A nanomolecular probe containing gold nanorods (GNRs) and perfluoropentane (PFP) coated with the cyclic Arg-Gly-Asp (cRGD) peptide were prepared by double emulsion solvent evaporation and carbodiimide methods. The morphology, particle size, potential, cRGD conjugation and absorption features of the nanomolecular probe were characterized, along with its in vitro phase transformation and photoacoustic/ultrasonic dual-modal imaging properties. In vivo fluorescence imaging was used to determine the distribution of cRGD-GNR-PFP-NPs in vivo in apolipoprotein E-deficient (ApoE−/−) atherosclerotic plaque model mice, the optimal imaging time was determined, and photoacoustic/ultrasonic dual-modal molecular imaging of integrin αvβ 3 expressed in atherosclerotic plaques was performed. Pathological assessments verified the imaging results in terms of integrin αvβ 3 expression and plaque vulnerability. Results: cRGD-GNR-PFP-NPs were spherical with an appropriate particle size (average of approximately 258.03± 6.75 nm), a uniform dispersion, and a potential of approximately − 9.36± 0.53 mV. The probe had a characteristic absorption peak at 780~790 nm, and the surface conjugation of the cRGD peptide reached 92.79%. cRGD-GNR-PFP-NPs were very stable in the non-excited state but very easily underwent phase transformation under low-intensity focused ultrasound (LIFU) and had excellent photoacoustic/ultrasonic dual-modal imaging capability. Mice fed a high-fat diet for 20 weeks had obvious hyperlipidemia with larger, more vulnerable plaques. These plaques could be specifically targeted by cRGD-GNR-PFP-NPs as determined by in vivo fluorescence imaging, and the enrichment of nanomolecular probe increased with the increasing of plaque vulnerability; the photoacoustic/ultrasound signals of the plaques in the high-fat group were stronger. The pathological assessments were in good agreement with the cRGD-GNR-PFP-NPs plaque accumulation, integrin αvβ 3 expression and plaque vulnerability results. Conclusion: A phase variant photoacoustic/ultrasonic dual-modal cRGD nanomolecular probe was successfully prepared and can be used to identify plaque vulnerability safely and effectively.


  • The 2-year postoperative left heart function in marginal donor heart recipients assessing by speckle tracking echocardiography

    by Xin Jiang, Yan-Xiang Zhou, Qing Zhou, Sheng Cao

    This study analyzed the differences and explored the donor/recipient factors between marginal and standard donor heart recipients after heart transplantation (HT) by speckle tracking echocardiography (STE). Seventy-two HT patients were enrolled: 25 standard and 47 marginal donor heart recipients. Thirty HT patients completed 2-year continuous follow-up (1, 6, 12, 24 months). Thirty healthy volunteers were controls. STE was used to track the strain characteristics of the left ventricle and atrium for detecting early changes in marginal donor heart recipients, including left ventricular global longitudinal, circumferential and radial strain (LVGLS, LVGCS, LVGRS) and left atrial strain in systole (LAS-S) and late diastole (LAS-A). The perioperative parameters were similar between the standard and marginal groups. No significant differences were found in left heart size, systolic and diastolic function parameters. Left ventricular systolic strain (LVGLS, LVGCS, LVGRS) and systolic and late diastolic left atrial strain (LAS-S, LAS-A) were lower in the HT recipients than the control group (P < 0.05), but there was no difference between the marginal and standard groups (P > 0.05). LVGLS, LVGCS, and LAS-S were low in the marginal group 1 month after surgery but recovered gradually at 6 months. The patients with donor/recipient body weight ratio < 0.8 group had lower LVGLS and LAS-S. STE showed no significant difference between marginal and standard donor recipients. The LVGLS and LAS-S were lower in those with a smaller donor/recipient body weight ratio. The cardiac function of HT patients was lower in the early postoperative period but gradually recovered over time.


  • Open Access

    Usefulness of postsystolic shortening and early systolic lengthening to detect reduced myocardial viability and predict future cardiovascular events in ST-segment elevation myocardial infarction

    by Wenyue Yuan, Yanxiang Zhou, Bo Hu, Mingqi Li, Jinling Chen, Ruiqiang Guo, Sheng Cao, Hongning Song

    Purpose: Postsystolic shortening (PSS) and early systolic lengthening (ESL) which represent asynchrony in ischemic myocardium can provide prognostic information in patients with ST-segment elevation myocardial infarction (STEMI). We aimed to investigate the potential of PSS and ESL to detect reduced myocardial viability and investigate the comparative prognostic value of PSS and ESL in patients with STEMI after primary PCI. Methods: We prospectively enrolled 198 patients with STEMI who underwent primary percutaneous coronary intervention. All patients took a speckle tracking echocardiographic examination and myocardial contrast echocardiography a median of 3 days after the percutaneous coronary intervention. Early systolic strain index (ESI), postsystolic strain index (PSI) and myocardial perfusion score index (MPSI) were calculated. The end point was major adverse cardiovascular events (MACE), a composite of all-cause death, unstable angina, heart failure, non-fatal recurrent myocardial infarction, stroke, and complex ventricular arrhythmia. Results: Reduced myocardial viability was defined as MPSI >1. Patients with category of MPSI >1.5 increased signifcantly with increasing tertiles of PSI (1.5% vs 7.6% vs 31.8%, p <0.001) and ESI (3.0% vs 12.1% vs 25.8%, p 1 was 0.745 and 0.704 in ROC analysis. During a median follow-up of 9.0 months (interquartile range [IQR], 6.0-12.0 months), 39 (19.7%) patients suffered MACE. PSI and ESI remained predictors of MACE in adjusted cox regression models. In ROC analysis, IDI and NRI of PSI were significantly higher compared to GLS while ESL didn’t. Conclusion: In patients with STEMI after primary PCI, PSS and ESL provides diagnostic information on reduced myocardial viability and offers prognostic information oncardiovascular events. Additionally, PSS emerged as independent predictor of mid- and long-term MACE with superior prognostic validity compared to GLS and ESL.

  • Open Access

    Predictive Value of the Transthoracic Echocardiography Index for Acute Kidney Injury after Cardiac Valve Surgery

    by Juan Guo, Yugang Hu, Sheng Cao, Chuangli Feng, Xin Huang, Qing Zhou

    Background: We aimed to demonstrate whether the preoperative transthoracic echocardiography index (TTEI) could improve the predictive value of clinical parameters for cardiac valve surgery-associated acute kidney injury (CVS−AKI). Methods: A total of 213 patients who underwent surgical CVS at Renmin Hospital of Wuhan University were consecutively recruited in this retrospective study. TTE assessments were performed within 7 days before surgery and logistic regression was used to determine TTEI. A nomogram was constructed by integrating TTEI and clinical features, and the net reclassification index (NRI) and integrated discrimination improvement (IDI) were applied to evaluate the improvement in TTEI for CVS−AKI. Results: Among them, 66 patients (30.9%) developed CVS−AKI. The TTEI was calculated as follows: −6.579 + 0.068 × pulmonary artery systolic pressure (mmHg) −0.742 × LVEF (>55%, yes or no) + 0.346 × left ventricle posterior wall thickness (mm). The nomogram based on the TEEI and other clinical factors possessed excellent performance (C-index = 0.880), had great calibration and discrimination, and was clinically useful. Furthermore, NRI (0.07, 95% confidence interval, 95%CI, 0.01–0.12, p = 0.02) and IDI (0.08, 95%CI, 0.01–0.20, p = 0.02) indicated that TTEI could significantly improve the predictive value of clinical features for CVS−AKI. Conclusions: As a simple access and cost-effective parameter, the preoperative TTEI may be a reliable and useful factor for CVS−AKI.


  • Open Access

    Platelet Membrane Biomimetic Nanoparticles Combined With UTMD to Improve the Stability of Atherosclerotic Plaques

    by Jia Zhou, Chengcheng Niu, Biying Huang, Sijie Chen, Caigui Yu, Sheng Cao, Wenjing Pei, Ruiqiang Guo

    Although research on the treatment of atherosclerosis has progressed recently, challenges remain in developing more effective, safer and transformative strategies for the treatment of atherosclerosis. Nanomaterials have recently played a unique role in many fields, including atherosclerosis treatment. Platelets are common component in the blood. Due to their inherent properties, platelets can target and adhere to atherosclerotic plaques. Ultrasound-targeted microbubble destruction (UTMD) shows great prospects in promoting the efficiency of drug delivery in treating solid tumors. In this study, we explored the possibility that UTMD assists platelet biomimetic rapamycin (RAP)-loaded poly (lactic-co-glycolic acid) (PLGA) nanoparticles (RAP@PLT NPs) in the treatment of atherosclerosis. The biomimetic nano-formulations exhibit better targeting ability to plaques when administered in vivo. Targeted destruction of Sonovue™ in the aortic area further improved the efficiency of targeting plaques. Moreover, the progression of atherosclerotic plaques was inhibited, and the stability of plaques was improved. Together, our study established a novel strategy for targeted delivery of nanoparticles in atherosclerotic plaques, by combining the advantages of the ultrasonic cavitation effect and biomimicking nanoparticles in drug delivery.


  • Top Cited Papers

    Characteristics and clinical significance of myocardial injury in patients with severe coronavirus disease 2019

    by Shaobo Shi, Mu Qin, Yuli Cai, Tao Liu, Bo Shen, Fan Yang, Sheng Cao, Xu Liu, Yaozu Xiang, Qinyan Zhao, et al.

    Aims: To investigate the characteristics and clinical significance of myocardial injury in patients with severe coronavirus disease 2019 (COVID-19). Methods and results: We enrolled 671 eligible hospitalized patients with severe COVID-19 from 1 January to 23 February 2020, with a median age of 63 years. Clinical, laboratory, and treatment data were collected and compared between patients who died and survivors. Risk factors of death and myocardial injury were analysed using multivariable regression models. A total of 62 patients (9.2%) died, who more often had myocardial injury (75.8% vs. 9.7%; P < 0.001) than survivors. The area under the receiver operating characteristic curve of initial cardiac troponin I (cTnI) for predicting in-hospital mortality was 0.92 [95% confidence interval (CI), 0.87–0.96; sensitivity, 0.86; specificity, 0.86; P < 0.001]. The single cut-off point and high level of cTnI predicted risk of in-hospital death, hazard ratio (HR) was 4.56 (95% CI, 1.28–16.28; P = 0.019) and 1.25 (95% CI, 1.07–1.46; P = 0.004), respectively. In multivariable logistic regression, senior age, comorbidities (e.g. hypertension, coronary heart disease, chronic renal failure, and chronic obstructive pulmonary disease), and high level of C-reactive protein were predictors of myocardial injury. Conclusion: The risk of in-hospital death among patients with severe COVID-19 can be predicted by markers of myocardial injury, and was significantly associated with senior age, inflammatory response, and cardiovascular comorbidities.


  • Open Access

    Unexplained pulmonary hypertension: an overlooked aortopulmonary window

    by Jinling Chen, Juan Guo, Sheng Cao

    A 15-year-old boy was born with cleft lip and palate and congenital aortic valve lesions. The symptoms of chest tightness and dizziness can be relieved after rest. A physical examination revealed slight cyanosis and grade 2/6 systolic murmur in the aortic valve auscultation area. The first echocardiography only found the aortic valve as a four-lobe deformity (Panel A) with moderate to severe regurgitation, but the severe systolic pulmonary hypertension (92 mmHg) was unexplained, there was no evidence of other congenital heart disease at parasternal short-axis view. Surgeons suspected a right-to-left shunt because the contrast agent entered the aorta when the right heart catheterization was used to measure the pulmonary artery pressure (Panel B; see Supplementary material online, Video S1). The second echocardiography confirmed there was no patent ductus arteriosus. However, a 3.0 cm wide communication opening with colour Doppler flow was revealed between the ascending aorta and the main pulmonary artery on the suprasternal notch section (Panels C and D; see Supplementary material online, Video S2). Contrast-enhanced echocardiography showed microbubbles passing between the ascending aorta and pulmonary artery (Panel E; see Supplementary material online, Video S3). The computed tomography angiography and 3D reconstruction also confirmed a wide connection (2.1 cm × 2.7 cm) between them (Panels F and G). The patient underwent repairment of the aortopulmonary septal defect (Panel H) and the replacement of quadricuspid aortic valve (Panel I) with mechanical prosthesis. He recovered well 2 weeks after operation and had significant decrease of the systolic pulmonary artery pressure (47 mmHg). Aortopulmonary window is an overlooked and very rare malformation as one cause of the pulmonary hypertension.